Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,915.00    -10.00 (-0.52%)
Bid:
1,910.00
Ask:
1,945.00
Spread: 35.00 (1.832%)
Market Cap: £232.69m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

AGM Statement and Trading Update

23 May 2019 07:00

RNS Number : 8769Z
S & U PLC
23 May 2019
 

23 May 2019

S&U plc

("S&U" or "the Group")

AGM Statement and Trading Update

S&U, the motor finance and bridging lender, issues a trading update for the period 1 February 2019 to 22 May 2019, prior to its AGM being held today.

Advantage Finance, S&U's motor finance business, continues to trade well with profits up on last year, whilst customer numbers now exceed 60,000 for the first time. Advantage's continuing policy of focussing on debt quality is proving its worth in light of current economic uncertainty, with current collections up 6% compared to net receivables, at £263m, up 3% against last year. Similarly, impairment has shown recent improvement and rolling 12-month risk adjusted yield is now slightly improved at just over 25% (31 January 2019: 24.6%).

These healthy indicators are also reflected in the record number of applications for finance that Advantage is currently receiving, averaging over 108,000 per month. This has meant that, even within the tightened under-writing regime, recent transaction volumes and quality as recorded in tiered tranches are showing improvement.

Aspen Finance, S&U's new property bridging lender, continues to make impressive progress. Its loan book now stands at £22m against £18m at year end, as its product range, introducer network and reputation continue to grow. This is evidenced in both the number of its recent illustrations and, most importantly, in its active deal pipeline, which is at a record level and has doubled over the period.

The Group's current progress has been reflected since year-end in an increase in Group borrowing from £108m to nearly £114m. This is well within our budgeted requirements and within our recently increased £160m medium term facilities, providing ample headroom for our anticipated growth.

Commenting on S&U's trading and outlook, Anthony Coombs, S&U Chairman, said:

"Recent trends in our business are encouraging, particularly in transaction growth, debt and new customer quality. Together with our tried and tested traditional emphasis on continuous process refinements and improvements for our customers, these give us confidence of further steady and sustainable growth and a successful year ahead."

Enquiries:

S&U

Anthony Coombs, Chairman 0121 705 7777

 

Newgate Communications

Bob Huxford, Tom Carnegie, Megan Kovach 020 7653 9848

 

Peel Hunt

Adrian Trimmings, Andrew Buchanan, Rishi Shah 020 7418 8900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMUUOARKBAVUAR
Date   Source Headline
20th May 20267:00 amRNSTrading Statement
13th May 20264:45 pmRNSAnnual Financial Report and Notice of AGM
8th May 20264:30 pmRNSDirector/PDMR Dealing
21st Apr 20267:00 amRNSPreliminary Results
13th Apr 20267:00 amRNSNotice of Results and Presentations
1st Apr 20267:00 amRNSFCA Redress Proposals
10th Feb 20267:00 amRNSTrading Statement and Notice of Results
11th Dec 20257:00 amRNSTrading Statement
17th Oct 20257:00 amRNSAppointment of Joint Broker
9th Oct 20257:00 amRNSInterim Results for the period ended 5 August 2025
6th Oct 20257:00 amRNSNotice of Investor Presentation
12th Aug 20257:00 amRNSTrading Update and Notice of Results
4th Aug 20257:00 amRNSSupreme Court motor finance ruling
8th Jul 20253:38 pmRNSDirector/PDMR Shareholding
18th Jun 20251:00 pmRNSResult of AGM
18th Jun 20257:00 amRNSAGM Statement and Trading Update
9th May 20254:45 pmRNSAnnual Report and Accounts and Notice of AGM
15th Apr 20257:00 amRNSPreliminary Results
7th Apr 20257:00 amRNSNotice of Results
11th Feb 20251:27 pmRNSAmendment to Trading Statement & Notice of Results
11th Feb 20257:00 amRNSTrading Update and Notice of Results
11th Dec 20247:00 amRNSTrading Statement
29th Oct 20242:00 pmRNSUpdate on Advantage Finance Limited
23rd Oct 20243:35 pmRNSDirector/PDMR and PCA Shareholding
23rd Oct 20242:00 pmRNSDirector/PDMR and PCA Shareholding
14th Oct 20247:00 amRNSUpdate on Advantage Finance Limited
8th Oct 20247:00 amRNSInterim Results for the 6 months to 31 July 2024
4th Oct 20247:00 amRNSNotice of Investor Presentation
19th Sep 20242:00 pmRNSTrading Update
12th Aug 20247:00 amRNSTrading Update and Notice of Results
6th Jun 20241:07 pmRNSResult of AGM
6th Jun 20247:00 amRNSAGM Statement and Trading Update
3rd May 20245:49 pmRNSDirector/PDMR and PCA Shareholding
3rd May 20242:00 pmRNSAnnual Report and Accounts
1st May 20244:19 pmRNSDirector/PDMR and PCA Shareholding
9th Apr 20247:00 amRNSPreliminary Unaudited FY Results to 31 Jan 24
25th Mar 20247:00 amRNSResults Presentations for Analysts and Investors
9th Feb 20247:00 amRNSTrading Statement and Notice of Results
1st Feb 20242:30 pmRNSNotice of Trading Update
11th Jan 20242:00 pmRNSDirector/PDMR Shareholding
12th Dec 20237:00 amRNSTrading Statement to 11 December 2023
31st Oct 20232:29 pmRNSDirector/PDMR and PCA Shareholding
5th Oct 20237:00 amRNSDirectorate Change
3rd Oct 20237:00 amRNSInterim Results for the 6 months to 31 July 2023
4th Sep 20237:00 amRNSNotice of Results and Investor Presentation
10th Aug 20237:00 amRNSTrading Update and Notice of Results
25th Jul 202311:34 amRNSDirector/PDMR Shareholding
17th Jul 20233:34 pmRNSDirector/PDMR Shareholding
26th May 20234:38 pmRNSDirector/PDMR Shareholding
25th May 202312:43 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.